Vanda Pharmaceuticals Inc. (VNDA) — DEF 14A Filings
All DEF 14A filings from Vanda Pharmaceuticals Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Vanda Pharma Files 2025 Proxy Statement on Executive Pay
— Apr 25, 2025 Risk: low
Vanda Pharmaceuticals Inc. filed its DEF 14A on April 25, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includ -
Vanda Pharmaceuticals Inc. Announces Annual Meeting of Stockholders on May 17, 2024
— Apr 29, 2024 Risk: medium
Vanda Pharmaceuticals Inc. (VNDA) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Annual Meeting of Stockholders to be held virtually on May 1
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX